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Hippocampal subfields have different vulnerability to the degenerative processes related
to aging, amnestic mild cognitive impairment (MCI) and Alzheimer’s disease (AD), but
the temporal evolution in Parkinson’s disease (PD) is unknown. The purposes of the
current work are to describe regional hippocampal changes over time in a sample of
PD patients classified according to their baseline cognitive status and to relate these
changes to verbal memory loss. T1-weighted images and verbal memory assessment
were obtained at two separate time points (3.8 ± 0.4 years apart) from 28 PD
with normal cognition (PD-NC), 16 PD with MCI (PD-MCI) and 21 healthy controls
(HCs). FreeSurfer 6.0 automated pipeline was used to segment the hippocampus into
12 bilateral subregions. Memory functions were measured with Rey’s Auditory Verbal
learning test (RAVLT). We found significant reductions in cornu ammonis 1 (CA1) over
time in controls as well as in PD subgroups. Right whole-hippocampal volumes showed
time effects in both PD groups but not in controls. PD-NC patients also displayed
time effects in the left hippocampal tail and right parasubiculum. Regression analyses
showed that specific hippocampal subfield volumes at time 1 predicted almost 60% of
the variability in RAVLT delayed-recall score decline. Changes in several hippocampal
subregions also showed predictive value for memory loss. In conclusion, CA1 changes
in PD were similar to those that occur in normal aging, but PD patients also had more
decline in both anterior and posterior hippocampal segments with a more pronounced
atrophy of the right hemisphere. Hippocampal segments are better predictors of changes
in memory performance than whole-hippocampal volumes.
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INTRODUCTION
Hippocampal atrophy is a key finding in neurodegenerative diseases (Camicioli et al., 2003; Small
et al., 2011; Bartsch and Wulff, 2015; Yang and Yu, 2017), although it is also present in healthy
aging (Fjell et al., 2014). In neuroimaging studies, the hippocampus has traditionally been assessed
as a single component, but more advanced techniques have allowed studying the hippocampus as
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a complex structure with specific regional vulnerability to aging
and subtypes of dementia (Small et al., 2011).
Extensive previous literature consistently reports region 1 of
the cornu ammonis (area CA1), the subiculum (Mueller et al.,
2010) and area CA3 (Pereira et al., 2014; Wisse et al., 2014) as
the regions that are most vulnerable to degeneration in normal
aging and Alzheimer’s disease (AD; de Flores et al., 2015).
In Parkinson’s disease (PD), hippocampal atrophy has been
associated with dementia (Junqué et al., 2005; Summerfield et al.,
2005; Ibarretxe-Bilbao et al., 2008), although volume reductions
can also be detectable in non-demented PD (Junqué et al., 2005;
Pereira et al., 2013) and even in unmedicated patients (Noh et al.,
2014).
The detection of regional hippocampal atrophy and its
association with memory decline is of high interest in PD
since memory impairment has been described as a risk
factor for dementia (Levy et al., 2002). Total hippocampal
volumes correlated with learning tasks (Pereira et al., 2013);
recognition memory, on the other hand, has been associated
with left hippocampal atrophy (Camicioli et al., 2003). More
recently, volume reductions in some subregions such as
areas CA2–3 and CA4 and the dentate gyrus (DG) have
been linked to verbal learning impairment in PD (Engvig
et al., 2012; Pereira et al., 2013). Moreover, CA2–3 atrophy
has been found to discriminate healthy controls (HCs)
from amnestic mild cognitive impairment (MCI) patients
better than global hippocampal volumes (Hanseeuw et al.,
2011).
In the last 3 years, thanks to the development of
automated segmentations tools, it has become possible to
divide the hippocampus into 12 bilateral segments based
on a statistical atlas built upon ultra-high resolution ex-vivo
MRI data (Iglesias et al., 2015). To our knowledge, only
one published study investigated differences in percentage
change over a 1.5-year follow-up between PD patients with
normal cognition (PD-NC) and with MCI (PD-MCI) in
hippocampal subfields also using this automated segmentation
pipeline (Foo et al., 2016). However, because it did not
include a HC group, this study could not distinguish
hippocampal atrophy due to normal aging from that due to
PD degeneration.
The aims of the present study were: (1) to investigate
longitudinal changes in hippocampal segments in a sample
of PD patients classified according to their baseline
cognitive status over a 4-year follow-up; (2) to examine
the predictive utility of specific hippocampal subfield
volumes as well as total volumes at time 1 to determine
changes in memory test scores over time in the PD
subgroups; and (3) to investigate the relationship between
hippocampal changes over time and memory performance
decline.
Based on the previous literature on aging, we would expect
that CA1 would be one of the segments atrophied over time,
but we would also expect to observe changes in other subfields
more specific of PD such as CA2–3. We also hypothesized that
the changes in total hippocampal volumes as well as specific
segments would explain progressive memory decline.
MATERIALS AND METHODS
Participants
Forty-four PD patients (PD-NC = 28; PD-MCI = 16) from the
PD and Movement Disorders Unit, Hospital Clinic (Barcelona,
Spain) and 21 HC from the Aging Institute in Barcelona
were assessed twice at an interval of 3.8 ± 0.4 years (range:
3.1–5.3).
At time 1, 90 PD patients and 32 HC were recruited between
October 2010 and March 2012. Detailed information of the
sample can be found in our previous work (Segura et al., 2014). In
the present study, only subjects who underwent comprehensive
neuropsychological and MRI acquisition at both times were
included.
At time 2, two patients underwent deep brain stimulation,
five patients and one HC died, 12 PD patients and two
controls refused to participate or had moved at follow-
up, three PD patients and three controls had developed
neurological/psychiatric comorbidities, 15 PD patients had
functional impairment and reduced mobility that prevented
going to the hospital for MRI scanning, six patients and
three HC had MRI motion artifacts or could not finish
the scanning protocol and three patients and two HC
were excluded due to problems in longitudinal image
preprocessing.
Inclusion criteria for patients at time 1 were: (i) fulfilling
the UK PD Society Brain Bank diagnostic criteria for PD
(Hughes et al., 1992); and (ii) no surgical treatment with
deep-brain stimulation. Exclusion criteria for PD patients
and HC were: (i) dementia according to the Movement
Disorders Society (MDS) criteria (Emre et al., 2007) and
to clinical assessment performed by a clinical neurologist
(MM, FV, YC); (ii) red flags for atypical parkinsonisms;
(iii) Hoehn and Yahr (H&Y) scale (Hoehn and Yahr, 1967)
score >3; (iv) young-onset PD; (v) age below 50 years; (vi)
presence of severe psychiatric or neurological comorbidity; (vii)
low global intellectual quotient estimated by the Vocabulary
subtest of the Wechsler Adult Intelligence Scale (scalar
score ≤ 7); (viii) Mini Mental State Examination (MMSE)
score (Folstein et al., 1975) below 25; (ix) claustrophobia;
(x) pathological MRI findings other than mild white matter
hyperintensities in the FLAIR sequence; and (xi) MRI artifacts.
At time 2, a diagnosis of dementia, H&Y score >3 and
MMSE scores below 25 were not considered as exclusion
criteria.
Motor symptoms were assessed with the Unified PD
Rating Scale motor section (UPDRS-III, Fahn and Elton,
1987). All PD patients were taking antiparkinsonian drugs,
consisting of different combinations of L-DOPA, catechol-
O-methyltransferase inhibitors, monoamine oxidase inhibitors,
dopamine agonists and amantadine. In order to standardize
doses, the L-DOPA equivalent daily dose (LEDD) was calculated
(Tomlinson et al., 2010).
Written informed consent was obtained from all study
participants after full explanation of the procedures. The study
was approved by the institutional Ethics Committee from the
University of Barcelona (IRB00003099).
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Neuropsychological and Clinical
Assessment
The diagnosis of PD-MCI was established in line with MDS
task force recommendations (Litvan et al., 2012) as previously
described in Segura et al. (2014). The memory domain was
assessed with Rey’s Auditory Verbal learning test (RAVLT; Lezak
et al., 2012) using total learning (RAVLT total), delayed recall
(RAVLT recall) and recognition (RAVLT recognition) scores.
Initially, z-scores for each test and for each subject were calculated
based on the control group’s means and standard deviations
(SDs) from time 1. Expected z-scores adjusted for age, sex and
education for each test and each subject were calculated based
on a multiple regression analysis performed in the HC group
(Aarsland et al., 2009).
Neuropsychiatric symptoms were evaluated with the Beck
Depression Inventory-II (Beck et al., 1996), Starkstein’s Apathy
Scale (Starkstein et al., 1992) and Cumming’s Neuropsychiatric
Inventory (Cummings et al., 1994).
Preprocessing of Longitudinal Imaging
MRI data were acquired with a 3T scanner (MAGNETOM
Trio, Siemens, Germany) at both times. The scanning protocol
included high-resolution 3-dimensional T1-weighted images
acquired in the sagittal plane (TR = 2,300 ms, TE = 2.98 ms,
TI = 900 ms, 240 slices, FOV = 256 mm; 1 mm isotropic voxel)
and an axial FLAIR sequence (TR = 9,000 ms, TE = 96 ms).
Cross sectional preprocessing of both times was estimated
using the automated FreeSurfer stream (version 5.11). Detailed
description of FreeSurfer procedures is reported in Segura et al.
(2014). In addition, to extract reliable volume and thickness
estimates, images were automatically processed with FreeSurfer’s
longitudinal stream (Reuter et al., 2012). Specifically, an unbiased
within-subject template space and image is created using robust,
inverse consistent registration (Reuter et al., 2010). Several
processing steps, such as skull stripping, Talairach transforms,
atlas registration as well as spherical surface maps and
parcellations are then initialized with common information from
the within-subject template, significantly increasing reliability
and statistical power (Reuter et al., 2012).
After longitudinal preprocessing, FreeSurfer version 6.0 was
used to segment the hippocampal subfields2. For a visual
representation of the hippocampal segments, see Figure 1.
Ratios were calculated for all hippocampal segment
volumes to global hippocampal volumes ((lh or rh
segments/lh or rh hippocampus)∗100). Global hippocampal
to estimated total intracranial volume ratios (eTIV, (lh or rh
hippocampus/eTIV)∗100) were also calculated.
Statistical Analysis
Cross-Sectional Analyses
Group differences in demographic variables and disease
outcomes were analyzed with Kruskal-Wallis tests followed
by Mann-Whitney-Wilcox’s pairwise comparisons and
1https://surfer.nmr.mgh.harvard.edu
2https://surfer.nmr.mgh.harvard.edu/fswiki/LongitudinalHippocampal
Subfields
FIGURE 1 | Coronal and sagittal view of the 12 bilateral segments in which
the hippocampus was automatically segmented as described by Iglesias et al.
(2015). Abbreviations: CA, cornu ammonis; GC-DG, granule cells in the
molecular layer of the dentate gyrus; HATA, hippocampal amygdala transition
area; HP_tail, hippocampal tail.
Bonferroni correction for quantitative measures. Pearson’s
chi-squared test was used where appropriate for categorical
measures. These analyses were conducted using RStudio
Version 1.1.419 (RStudio Team, 2015); information on the
libraries and functions can be found in Supplementary
Methods S1.
A general linear model and Monte Carlo permutation
testing with 10,000 iterations were applied to perform group
comparisons of hippocampal volumes ratios at time 1 using
Matlab R2017a (The MathWorks Inc., Natick, MA, USA). To
control type-I errors, a Bonferroni correction was applied. Age
and years of education were included as covariates of no interest.
Repeated Measures Analyses
Repeated measures analyses were also conducted with Matlab
as described above. Main effects of time and group-by-
time interaction were tested on clinical variables such as
UPDRS, LEDD and neuropsychiatric symptoms, on memory
performance scores and hippocampal subfield volumes between
PD groups and HC. Age at time 1 and years of education were
used as covariates of no interest in longitudinal hippocampal
subfield analyses. For repeated memory score analyses, we used
the z-scores adjusted for age, education and sex as described
above. Bonferroni correction was applied to all analyses.
Multiple Regression Analyses in the PD Patient
Sample
Two different multiple linear regression analyses were performed
using two models. As a response variable, both models included
the difference between time 2 minus time 1 RAVLT raw scores
in total learning, recall and recognition. The first model included
age at time 1, years of education and hippocampal segments as
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predictors. The second model included age at time 1, years of
education and whole hippocampal volumes as predictors.
First, we assessed the predictive utility of hippocampal ratios
at time 1 to explain the variability in memory performance
changes. Second, we included the change in hippocampal ratios
(time 2− time 1) as explanatory variables of memory change.
A stepwise model selection by Akaike information criterion
(AIC) was applied on the multiple linear regression models
described above. This method picks the best-fitted model
that most adequately describes an unknown, high dimensional
reality (Zhang, 2016). Resulting hippocampal structures that best
described prediction of changes in memory performance can be
found in Supplementary Methods S2.
Finally, only multiple regression models with statistical
significance are reported. Within the RAVLT recall models, an
ANOVA was used to test if there were significant differences
between the segments model and the global volumes model.
RESULTS
Demographic Characteristics and Clinical
Evolution
There were no significant differences in scan interval between
groups (H = 0.013; P = 0.994). Thus, involution of the
hippocampus and memory can be directly compared. Moreover,
the groups had similar disease duration and H&Y staging scores.
Although not significant at p < 0.05, subjects in the HC group
were older than those in the PD subgroups; for this reason, age
was included as a covariate in group analyses and as a variable
of interest in multiple regression models as described in the
‘‘Materials and Methods’’ section (Table 1).
Table 2 summarizes the time effects observed for the clinical
measures. The collapsed PD sample had significant decline over
time in global cognition scores, increased motor severity as
measured by the UPDRS-III and increased neuropsychiatric
symptoms. All the PD groups had increased neuropsychiatric
symptoms and PD-NC also showed increased depression scores.
No significant changes were seen in apathy scale scores.
Longitudinal Changes in Hippocampal
Segments
Longitudinally, both PD-NC and PD-MCI as well as the PD
collapsed sample showed a significant time effect in the right
whole hippocampus. Regarding time effects in hippocampal
segments, the right CA1 displayed a significant effect of
time in all groups of PD patients and HC. Moreover, the
left hippocampal tail (HP_tail) and right parasubiculum had
significant decreases in the PD collapsed sample and PD-NC
patients. Significant group-by-time interaction was seen in the
right parasubiculum in the contrast HC vs. PD-NC and PD-NC
vs. PD-MCI. Means and SDs of hippocampal segments can be
found in Supplementary Table S1; test stats and uncorrected
P-values can be found in Table 3. After Bonferroni correction,
P-values were not significant.
Predictive Utility of Hippocampal Volumes
in Memory Decline
Memory Decline
Regarding memory performance, all z-scores were lower at
follow-up. The collapsed PD sample showed significant decline
in all variables mainly due to progressive impairment in the
PD-NC group. PD-NC had a significant decrease in RAVLT total
learning and recognition (Table 4). For RAVLT total learning,
there was a significant group-by-time interaction between
PD-NC and HC (t = 2.301; P = 0.013; P-corrected < 0.05). For
RAVLT recognition, the interaction was significant for PD-NC
and HC (t = 2.969; P < 0.001; P-corrected< 0.05) and for all PD
sample vs. controls (t = 2.713; P < 0.001; P-corrected = 0.05).
TABLE 1 | Demographic and clinical characteristics of the sample at both times.
PD-NC PD-MCI PD whole sample Controls Test stats P-value
n = 28 n = 16 n = 44 n = 21
Age, years, median (IQ range)
Time 1 59.0 (11.8) 61.5 (17.3) 60.0 (10.5) 67.0 (13.0) H = 6.2261
U = 593.02
0.0441
0.0672
Time 2 63.5 (12.5) 66.0 (15.8) 64.5 (12.0) 70.0 (12.0) H = 5.7951
U = 590.02
0.0551
0.0732
Education, years, median (IQ range) 13.0 (8.3) 10.0 (7.5) 12.0 (8.3) 10.0 (7.0) H = 1.5831
U = 405.02
0.4531
0.4262
Sex, female, n (%) 8 (28.6) 6 (37.5) 14 (31.8) 10 (47.6) X2 = 1.8721
X2 = 0.9212
0.3921
0.3372
Disease duration, years, median (IQ range)
Time 1 6.0 (5.0) 6.0 (9.5) 6.0 (7.5) NA U = 197.5 0.759
Time 2 9.0 (4.0) 8.0 (8.3) 9.0 (6.3) NA U = 248.0 0.565
Age of onset, years, median (IQ range) 53.5 (15.8) 55.3 (15.8) 54.0 (15.8) NA U = 180.0 0.294
Hoehn &Yahr stage, n 1/1.5/2/2.5/3/4
Time 1 11/1/12/2/2/0 6/0/8/1/1/0 17/1/20/3/3/0 NA X2 = 0.718 0.949
Time 2 3/0/14/0/11/0 3/0/5/0/7/1 6/0/19/0/18/1 NA X2 = 3.111 0.375
IQ range, interquartile range; NA, not applicable; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition. P-values
are from Kruskal-Wallis test followed by Mann-Whitney pairwise test and Bonferroni correction for continuous variables and chi-squared test for categorical variables.
1Test stats and P-values of PD subgroups and HC comparisons. 2Test stats and P-values of the PD collapsed sample and HC comparisons.
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TABLE 2 | Repeated clinical measures.
PD-NC PD-MCI PD all sample Controls Time effects
n = 28 n = 16 n = 44 n = 21 PD-NC PD-MCI PD all sample Controls
Mini Mental State Examination, mean (SD)
Time 1 29.5 (0.7) 28.7 (1.5) 29.2 (1.1) 29.8 (0.4) t = 1.366;
P = 0.055
t = 2.957;
P = 0.050
t = 2.843;
P = 0.007∗
t = 1.291;
P = 0.052
Time 2 29.1 (1.0) 27.6 (3.4) 28.6 (2.3) 29.3 (0.9)
UPDRS part III, mean (SD)
Time 1 13.9 (9.2) 11.8 (11.0) 13.1 (9.8) NA t = 1.533;
P = 0.052
NS t = 2.073;
P = 0.022∗
NA
Time 2 17.8 (9.0) 17.4 (12.7) 17.7 (10.3) NA
LEDD, mg, mean (SD)
Time 1 700.8 (470.6) 675.6 (535.2) 691.6 (489.0) NA NS NS NS NA
Time 2 720.5 (388.2) 693.3 (481.1) 710.6 (419.0) NA
Beck Depression Inventory II, mean (SD)
Time 1 7.3 (4.9) 11.1 (6.3) 8.7 (5.7) 7.0 (5.4) t = 1.508;
P = 0.043∗
NS NS NS
Time 2 8.5 (7.4) 10.0 (6.3) 9.1 (7.0) 5.3 (4.7)
Starkstein’s Apathy Scale, mean (SD)
Time 1 10.6 (5.7) 14.3 (8.7) 11.9 (7.0) 9.1 (5.6) NS NS NS NS
Time 2 11.4 (6.6) 14.1 (9.4) 12.4 (7.7) 9.3 (5.6)
Cummings’ Neuropsychiatric Inventory, mean (SD)
Time 1 4.5 (7.2) 9.1 (11.8) 6.2 (9.3) 1.9 (3.6) t = 1.993;
P = 0.041∗
t = 2.343;
P = 0.041∗
t = 3.016;
P = 0.006∗
NS
Time 2 7.1 (8.8) 13.1 (11.6) 9.3 (10.2) 2.3 (2.6)
LEDD, L-DOPA equivalent daily dose; NA, not applicable; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition;
SD, standard deviation; UPDRS part III, Unified Parkinson’s Disease Rating Scale motor section. NS, non-significant. ∗P-values < 0.05 after Bonferroni correction.
TABLE 3 | Time effects and group-by-time interaction for significant hippocampal segments.
Time effects Interaction time × group
PD-NC PD-MCI PD all
sample
Controls HC >
PD-NC
HC >
PD-MCI
PD-NC >
PD-MCI
HC > PD
all sample
Left hippocampal tail t = 1.923;
P = 0.019
NS t = 1.764;
P = 0.028
NS
Right CA1 t = 1.682;
P = 0.030
t = 2.082;
P = 0.019
t = 1.864
P = 0.027
t = 2.037
P = 0.023
Right parasubiculum t = 1.985
P = 0.035
NS t = 1.932
P = 0.026
NS t = 1.498;
P = 0.031
t = −2.574
P = 0.020
Right whole hippocampus t = 1.614;
P = 0.031
t = 1.539;
P = 0.040
t = 1.626;
P = 0.030
NS
CA, Cornu Ammonis; HC, healthy controls; NS, non-significant; PD-MCI, Parkinson’s disease mild cognitive impairment; PD-NC, Parkinson’s disease normal cognition.
Hippocampal Volume Ratios at Time 1 as Predictors
of Memory Change Over Time
The first multiple regression approach investigated whether
hippocampal volume ratios at time 1 can be good predictors of
memory performance change.
For RAVLT total changes over time, using whole
hippocampal volume ratios as predictors, the right whole
hippocampus was a significant predictive variable (R2 = 0.16;
adjusted R2 = 0.14; F = 8.074; P = 0.007). However, the segments
model for change over time was not significant (R2 = 0.26;
adjusted R2 = 0.07; F = 1.332; P = 0.257).
For RAVLT recall change, the significant predictive variables
were age, left CA3, right CA4, left parasubiculum, right
subiculum, right fimbria, right HP_tail, right fissure and left
molecular layer (R2 = 0.69; adjusted R2 = 0.56; F = 5.634;
P < 0.001). Considering that the bilateral whole hippocampus
was a significant predictor (R2 = 0.23; adjusted R2 = 0.19;
F = 5.960; P = 0.005), there were significant differences between
the segments and the global volumes models (F = 4.539;
P = 0.001).
Regarding RAVLT recognition change, the bilateral CA1,
right CA4, bilateral subiculum and right Hippocampal Amygdala
Transition Area (HATA) were significant predictive variables
(R2 = 0.44; adjusted R2 = 0.27; F = 2.557; P = 0.021).
Detailed information of the multiple regression models for
each test can be found in Supplementary Table S2.
Relationship Between Hippocampal Volume Ratio
Change and Memory Decline
The second multiple regression approach aimed to investigate
whether changes in hippocampal volume ratios can explain
changes in memory performance.
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TABLE 4 | Repeated measures analysis of memory performance.
PD-NC
n = 28
mean (SD)
PD-MCI
n = 16
mean (SD)
PD all sample
n = 44
mean (SD)
Controls
n = 21
mean (SD)
Time effects
PD-NC PD-MCI PD all sample Controls
RAVLT total learning
Time 1 0.14 (1.12) −1.52 (0.80) −0.47 (1.29) 0.00 (0.81) t = 3.836;
P = 0.001∗
NS t = 3.315;
P = 0.001∗
NS
Time 2 −0.58 (1.30) −1.66 (1.25) −0.97 (1.37) −0.06 (0.73)
RAVLT delayed recall
Time 1 −0.15 (1.12) −1.30 (0.94) −0.57 (1.19) 0.06 (0.90) NS NS t = 1.956;
P = 0.034
NS
Time 2 −0.46 (1.38) −1.70 (1.10) −0.91 (1.41) −0.04 (0.74)
RAVLT recognition
Time 1 0.20 (1.04) −0.95 (2.23) −0.22 (1.65) −0.17 (0.76) t = 4.059;
P< 0.001∗
NS t = 4.178;
P < 0.001∗
NS
Time 2 −1.38 (2.85) −1.76 (1.86) −1.51 (2.52) 0.01 (0.94)
NS, not significant; PD-MCI, Parkinson’s disease with mild cognitive impairment; PD-NC, Parkinson’s disease with normal cognition; RAVLT, Rey’s auditory verbal learning
test. Means are adjusted z-scores by age, years of education and sex. ∗ Indicates statistical significance (P-values < 0.05) after Bonferroni correction.
Changes in right fimbria, right HP_tail and left fissure were
significant explanatory variables of changes in RAVLT recall
scores (R2 = 0.67; adjusted R2 = 0.45; F = 3.093; P = 0.005). In
the global model, the left hippocampus was the only significant
variable (R2 = 0.20; adjusted R2 = 0.14; F = 3.240; P = 0.032).
There were significant differences between the two models
(F = 2.659; P = 0.015).
Finally, for RAVLT recognition, when considering the whole
structure (R2 = 0.14; adjusted R2 = 0.12; F = 6.589; P = 0.014), the
left hippocampus was a significant predictor.
Information regarding the multiple regression models for
each test can be found in Supplementary Table S3.
DISCUSSION
The main findings of the present study were: (1) the right
CA1 was sensitive to time effects in normal aging and in PD
with NC and with MCI; (2) volume decrements in right whole
hippocampus volume as well as specific regional volumes were
only found in PD; and (3) hippocampal subfields were better
predictors of delayed verbal memory recall decline than global
hippocampal volumes.
The right CA1 showed a significant time effect for all PD
groups and for HC. No significant group-by-time interactions
were found. Therefore, the changes observed seem to be due
to aging effects rather than specific of PD. CA1 has been
reported as one of the regions with the earliest and strongest
involvement over time in AD (Small et al., 2011), being useful
to discriminate healthy subjects from those with MCI (Mueller
et al., 2010) and to predict conversion from MCI to AD
(Apostolova et al., 2010). Indeed, early neuropathological studies
have described a high susceptibility to the accumulation of
amyloid-β in CA1 both in a mouse model and humans (Furcila
et al., 2018).
Cross-sectional studies have reported that the head of the
hippocampus is the most vulnerable region in normal aging (Ta
et al., 2012), in non-demented PD (Ibarretxe-Bilbao et al., 2008)
and in demented PD patients (Bouchard et al., 2008; Ibarretxe-
Bilbao et al., 2008) but demented patients also revealed posterior
hippocampal atrophy (Ibarretxe-Bilbao et al., 2008). In the
present longitudinal study, in addition to the decrements
described above, we also found significant volume decrements
in the left HP_tail for the PD-NC group, suggesting that specific
posterior hippocampal atrophy takes place at earlier stages of the
disease.
When considering global hippocampal volumes, the right
hippocampus had specific time effects in all PD subgroups. This
pattern is different from what occurs in amnestic MCI and AD.
In ameta-analysis of 14 studies it has been reported that although
in both MCI and AD there are progressive bilateral reductions,
the effect size is greater for the left hemisphere when compared
with the right (Shi et al., 2009). A recent work by Yue et al.
(2018) reported hippocampal asymmetry in MCI patients and
individuals with subjective cognitive decline compared with HC
where the left hemisphere was more atrophic than the right.
The right parasubiculum was also sensitive to time effects
in the PD-NC group. Volume decrements in this region were
significantly higher than those observed in the HC and the
PD-MCI group as demonstrated by the significant group-by-
time interaction. The parasubiculum is a small hippocampal
structure that is usually studied together with the subiculum
and parasubiculum. Therefore, there is not much previous
literature using MRI techniques describing the implication of
this structure in aging or neurodegenerative processes. However,
we could speculate that the volume decrements found in
the right parasubiculum might be related to parietal atrophy
through transneuronal degeneration. The parasubiculum has
direct projections to medial parieto-temporal regions involved
in visuospatial processes (Dalton and Maguire, 2017). In
PD, there is a structural temporo-parietal atrophy suggested
as a marker of cognitive decline (Segura et al., 2014).
More specifically, medial parietal atrophy has been linked to
visuospatial impairment in PD patients (Garcia-Diaz et al.,
2014).
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Regarding memory performance, hippocampal segment
volumes as well as whole hippocampal volumes at baseline
have been reported as significant predictors of verbal memory
delayed recall changes (Beyer et al., 2012). In our study, the
segments model explained 56% of the variability, whereas
the whole hippocampal volumes model only explained 19%.
In line with this, the right fimbria, right HP_tail and left
fissure volume changes over time were linked to changes
in RAVLT recall changes in a model that explained almost
50% of the variance. By contrast, the whole hippocampal
model was more useful to predict changes in RAVLT total
learning scores, although these models did not explain
much variability. We could speculate that declines in
verbal memory learning would be related to hippocampal-
neocortical connectivity more than based on structural changes
in the hippocampal formation per se (Fjell et al., 2016).
Finally, models including RAVLT recognition changes also
explained less than 50% of the variance, with the segments
model explaining more variance than the global volumes
model.
The strengths of the present study are: the inclusion of a
control group allowed us to compare hippocampal atrophy in PD
with atrophy that occurs in elderly healthy subjects as part of the
aging process. Also, the use of novel neuroimaging automated
pipelines to accurately segment the hippocampus to investigate
regional vulnerability. FreeSurfer’s pipeline is based on ex vivo
7T images to manually segment the hippocampus in order to
create the statistical atlas; and it has been recently proved to
have a good test-retest reliability over time (Worker et al., 2018).
However, the authors (Iglesias et al., 2015) recommend caution
on the interpretation of results involving the internal subfields
such as the CA4, molecular layer or the Granule cells in the
molecular layer of the DG. To the best of our knowledge, there is
no study that compares the subfields overlap with other manual
or automated segmentations methods.
The most important limitation would be the small sample
size due to a high attrition rate in the Parkinson’s cohort.
To overcome this problem, which affects generalization of the
results, larger multicentric studies in PD should help clarify the
progressive pattern of degeneration in the hippocampus. There
are few longitudinal studies in PD cohorts performing MRI
assessments over more than 1.5 years of follow-up. The work of
Ulla et al. (2013) followed a cohort of PD patients over 3 years
and they also reported an attrition rate of 50%. Multicentric
longitudinal initiatives are particularly common in AD, such as
the ADNI database3 or the AIBL initiative. In the longitudinal
AIBL cohort, almost 60% of the participants returned toMRI and
PET follow-up scans (Doré et al., 2013). This relatively higher
percentage could be explained because elder controls and AD
patients have lessmotor impairment than PD patients.Moreover,
we would like to highlight as a frequent limitation of longitudinal
studies that participants with worse disease prognosis, with
more depressive/apathetic symptoms or with greater functional
impairment in their daily living are more likely to be lost to
follow-up.
3http://adni.loni.usc.edu/
It could be also mentioned that, due to the exploratory
nature of the hippocampal subfield study, we report
uncorrected P-values. These results should thus be interpreted
with caution. This limitation is common to all studies
using these new hippocampal segmentations; however,
exploratory analyses are necessary to progress in neuroimaging
research.
In conclusion, besides regional vulnerability in hippocampus
degeneration dependent in part of aging, we found specific
hippocampal regions that were more sensitive to time effects
in PD. The right global hippocampus also seems to be more
vulnerable than the left. Finally, specific hippocampal segment
volumes were found to be good markers of verbal delayed recall
performance decline over time.
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